rs80359861
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001017420.3(ESCO2):c.1131+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000025 in 1,601,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001017420.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESCO2 | ENST00000305188.13 | c.1131+1G>A | splice_donor_variant, intron_variant | Intron 6 of 10 | 1 | NM_001017420.3 | ENSP00000306999.8 | |||
ESCO2 | ENST00000522378.5 | n.*106+1G>A | splice_donor_variant, intron_variant | Intron 4 of 11 | 1 | ENSP00000428928.1 | ||||
ESCO2 | ENST00000397418.4 | c.75+1G>A | splice_donor_variant, intron_variant | Intron 1 of 6 | 5 | ENSP00000380563.2 | ||||
ESCO2 | ENST00000518262.5 | c.243+1G>A | splice_donor_variant, intron_variant | Intron 3 of 5 | 3 | ENSP00000428959.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250830Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135642
GnomAD4 exome AF: 0.0000255 AC: 37AN: 1449374Hom.: 0 Cov.: 26 AF XY: 0.0000249 AC XY: 18AN XY: 721878
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74300
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change affects a donor splice site in intron 6 of the ESCO2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ESCO2 are known to be pathogenic (PMID: 15821733, 16380922). This variant is present in population databases (rs80359861, gnomAD 0.002%). Disruption of this splice site has been observed in individuals with Roberts syndrome (PMID: 16380922, 19574259). ClinVar contains an entry for this variant (Variation ID: 21233). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Roberts-SC phocomelia syndrome Pathogenic:1Other:1
- -
The splice site variant c.1131+1G>A in the ESCO2 gene has been reported in homozygous state in individuals affected with Roberts syndrome (Schüle B. et al., 2005). This variant is reported with the allele frequency (0.0004%) in gnomAD and novel in 1000 genome database. It has been submitted to ClinVar as a Pathogenic variant. The variant affects the invariant GT donor splice site of exon 6. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. The same variant has been observed in heterozygous state in the spouse. -
Roberts syndrome Pathogenic:1
- -
Roberts-SC phocomelia syndrome;C0796099:Juberg-Hayward syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at